Skip to main content
. 2020 Feb 26;8(4):700–712. doi: 10.12998/wjcc.v8.i4.700

Table 2.

Clinical information and ultrasonography, and color Doppler flow imaging between benign and malignant non-mass-like lesions

Parameter Pathology, n (%)
Total χ2 P value
Benign Malignant
Age in yr ﹤45 18 (64.29) 9 (39.13) 27 (52.94) 3.207 0.073
≥ 45 10 (35.71) 14 (60.87) 24 (47.06)
Palpability No 19 (67.86) 12 (52.17) 31 (60.78) 1.303 0.254
Yes 9 (32.14) 11 (47.83) 20 (39.22)
Nipple discharge No 20 (71.43) 18 (78.26) 38 (74.51) 0.31 0.577
Yes 8 (28.57) 5 (21.74) 13 (25.49)
Echogenicity Hypo-echoic 14 (50.00) 13 (56.52) 27 (52.94) 0.216 0.642
Mixed-echoic 14 (50.00) 10 (43.48) 24 (47.06)
Ductal changes No 17 (60.71) 12 (52.17) 29 (56.86) 0.375 0.54
Yes 11 (39.29) 11 (47.83) 22 (43.14)
Rear echo attenuation No 25 (89.29) 16 (69.57) 41 (80.39) 1.99 0.158
Yes 3 (10.71) 7 (30.43) 10 (19.61)
Architectural distortion No 27 (96.43) 17 (73.91) 44 (86.27) 1.043 0.307
Yes 1 (3.57) 6 (26.09) 7 (13.73)
Microcalcifications No 24 (85.71) 10 (43.48) 34 (66.67) 10.137 0.001b
Yes 4 (14.29) 13 (56.52) 17 (33.33)
Axillary lymph node Normal 26 (92.86) 17 (73.91) 43 (84.31) 1.274 0.237
Abnormal 2 (7.14) 6 (26.09) 8 (15.69)
CDFI Scarce 19 (67.86) 14 (60.87) 33 (64.71) 0.27 0.603
Abundant 9 (32.14) 9 (39.13) 18 (35.29)
b

P < 0.01. CDFI: Color Doppler flow imaging.